Spotlighting Development & Therapeutic Potential of ZW327: a Novel Ly6E Targeting ADC Against Solid Tumors

  • Exploring target characteristics, solid tumor expressions rationale for re-exploring Ly6E as a novel ADC target 
  • Showcasing design and development of ZW327 across anti-Ly6E antibody generation paired with novel topo1 payload 
  • Exploring preliminary findings and future development plans for ZW327 across solid tumor indications